A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

The patient support program Cycle Vita will be available for people with MS taking Bafiertam (monomethyl fumarate) starting ...

Fooling others — and himself — into believing his MS symptoms weren't a big deal wasn't a good approach, writes columnist Be.

“These findings reaffirm that the current Ocrevus IV 600 mg is optimally dosed to significantly slow disability progression,” ...

In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment ...

Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial ...

Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...

A local naval officer is fearlessly facing his multiple sclerosis diagnosis, using his creativity and entrepreneurial skills ...

Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide additional benefit to people living with relapsing multiple sclerosisThe trial ...